EssilorLuxottica stock supported by buybacks as shares trade above EUR 160
Published on 08/30/2026 at 16:33 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
EssilorLuxottica (FR0000033219) stock has been trading above EUR 160 in late August 2026 as the company continues to execute a share buyback program that included the repurchase of 137,964 shares between August 17, 2026 and August 21, 2026 at a daily weighted average price of EUR 159.8694 per share per the disclosure of transactions in own shares.
Buyback activity and recent price levels
According to the disclosure covering the period from August 17, 2026 to August 21, 2026, EssilorLuxottica repurchased 137,964 shares under a share buyback authorization granted by shareholders, paying a daily weighted average price of EUR 159.8694 for these shares as disclosed in the buyback report.
Recent market data from a European equity overview show that EssilorLuxottica shares on Euronext traded at EUR 161.35 with a gain of EUR 10.75, corresponding to a 2.40 percent advance in that session, highlighting that the latest close stands EUR 1.48 above the weighted average repurchase price cited in the August buyback disclosure based on a European market agenda overview.
Valuation context and analyst fair value estimate
An equity research summary discussing EssilorLuxottica shares notes that the stock recently closed at EUR 161.35 while a modeled fair value estimate places the company at EUR 242.65, suggesting a gap of EUR 81.30 between the current price point and that valuation reference according to an equity valuation analysis.
The same valuation discussion frames this difference as a discount relative to intrinsic value models, implying that if the fair value estimate were realized, EssilorLuxottica shares would need to rise more than 50 percent from the EUR 161.35 reference price to reach the cited EUR 242.65 level, even as the company uses buybacks to reduce share count over time based on the same valuation overview.
Go deeper
Investor Relations
More on EssilorLuxottica stock
Investors can find broader financial information and corporate presentations for EssilorLuxottica through the companys investor relations section, which provides access to earnings materials, capital allocation updates, and long-term strategic plans.
Ray-Ban and eyecare portfolio
EssilorLuxottica is known for designing, manufacturing, and distributing ophthalmic lenses, eyeglass frames, and sunglasses under brands such as Ray-Ban and others, serving customers across North America, Europe, Latin America, the Middle East, Africa, and the Asia-Pacific region as described in a business profile.
This combination of prescription lenses, optical retail networks, and iconic sunglass brands provides EssilorLuxottica with diversified revenue streams across both medical and fashion segments, supporting a business model that can balance demand in corrective eyewear with consumer trends in premium sunglasses.
EssilorLuxottica stock on Euronext
EssilorLuxottica shares are listed on Euronext Paris under the ticker EL, and recent quote information for the companys over-the-counter listing in the United States indicates a price of $93.72 for the ESLOY American depositary receipt as of August 28, 2026 at 3:59 p.m. Eastern time, with a session gain of $2.15 corresponding to a 2.35 percent increase for that day based on a US market quote overview.
The parallel move in the European listing, with a close at EUR 161.35 and a 2.40 percent gain, and in the US over-the-counter instrument, with a 2.35 percent gain, suggests that EssilorLuxottica stock has recently been supported across both markets as investors respond to ongoing buybacks and valuation discussions.
Fact box
Company: EssilorLuxottica Societe anonyme
ISIN: FR0000033219
Ticker: EL (Euronext Paris), ESLOY (OTC US)
Exchange: Euronext Paris, OTC US
Price (as of August 28, 2026, 3:59 p.m. ET): $93.72 USD for ESLOY
Sector / Industry: Health care - Medical equipment and supplies
Index membership: CAC 40
